Phenprocoumon
CAS No. 435-97-2
Phenprocoumon( —— )
Catalog No. M20960 CAS No. 435-97-2
Phenprocoumon is an antagonist of vitamin K(IC50:1 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 42 | Get Quote |
|
| 25MG | 73 | Get Quote |
|
| 50MG | 115 | Get Quote |
|
| 100MG | 174 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePhenprocoumon
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhenprocoumon is an antagonist of vitamin K(IC50:1 μM).
-
DescriptionPhenprocoumon is an antagonist of vitamin K(IC50:1 μM).(In Vivo):After a single i.v.-dose of phenprocoumon (0.355 mg/kg) the anticoagulant effect obtained is greater in older than in younger rats. There are no differences between younger and older rats in the rate of elimination, volume of distribution and in the free fraction and free concentration values of phenprocoumon in plasma and liver. After i.v.-injection of 64.3 μg/kg [3H]vitamin K1 and different doses of phenprocoumon (0.02 to 3 mg/kg) the [3H]vitamin K1 concentration in the liver decreases and the [3H] vitamin K1-2, 3-epoxide concentration increases dependent on the dose and the liver concentration of phenprocoumon. These changes are more pronounced in the older than in the younger rats.
-
In Vitro——
-
In VivoAfter a single i.v.-dose of phenprocoumon (0.355 mg/kg) the anticoagulant effect obtained is greater in older than in younger rats. There are no differences between younger and older rats in the rate of elimination, volume of distribution and in the free fraction and free concentration values of phenprocoumon in plasma and liver. After i.v.-injection of 64.3 μg/kg [3H]vitamin K1 and different doses of phenprocoumon (0.02 to 3 mg/kg) the [3H]vitamin K1 concentration in the liver decreases and the [3H] vitamin K1-2, 3-epoxide concentration increases dependent on the dose and the liver concentration of phenprocoumon. These changes are more pronounced in the older than in the younger rats.
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetVitamin
-
Recptorvitamin K
-
Research AreaCardiovascular Disease
-
Indicationthromboembolic disease
Chemical Information
-
CAS Number435-97-2
-
Formula Weight280.32
-
Molecular FormulaC18H16O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (445.92 mM)
-
SMILESCCC(c1ccccc1)c1c(O)c2ccccc2oc1=O
-
Chemical Name4-hydroxy-3-(1-phenylpropyl)chromen-2-one
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Martin Müller Fabian et al. Characteristics treatment and outcome of bleeding after tooth extraction in patients on DOAC and phenprocoumon compared to non-anticoagulated patients-a retrospective study of emergency department consultations.[J]. Clinical oral investigations 2018.
molnova catalog
related products
-
MeTC7
MeTC7 is a vitamin D receptor (VDR) antagonist with antitumor activity that inhibits PD-L1 and may inhibit the growth of xenografts and transgenic tumors in vivo.
-
L(+)-Ascorbic acid
Vitamin C is a water-soluble vitamin indicated for the prevention and treatment of scurvy.
-
Cyanocobalamin
Vitamin B12 is a water soluble vitamin with a key role in the normal functioning of the brain and nervous system, and for the formation of blood.
Cart
sales@molnova.com